1,3-dipropyl-8-cyclopentylxanthine has been researched along with Infarct in 1 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We used adenosine A1 receptor agonist N6-1(phenyl-2R-isopropyl)-adenosine (PIA), A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), and ATP-sensitive K+ (KATP) channel blockers sodium 5-hydroxydecanoate (5-HD) and glibenclamide (Glib), as probes to investigate the role and mechanism of adenosine in ischemic preconditioning (IPC) of noncontractile skeletal muscle against infarction, using the pig latissimus dorsi muscle flap model." | 7.69 | Effector mechanism of adenosine in acute ischemic preconditioning of skeletal muscle against infarction. ( Forrest, CR; He, W; Neligan, P; Pang, CY; Xu, H; Zhong, A, 1997) |
| "We used adenosine A1 receptor agonist N6-1(phenyl-2R-isopropyl)-adenosine (PIA), A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), and ATP-sensitive K+ (KATP) channel blockers sodium 5-hydroxydecanoate (5-HD) and glibenclamide (Glib), as probes to investigate the role and mechanism of adenosine in ischemic preconditioning (IPC) of noncontractile skeletal muscle against infarction, using the pig latissimus dorsi muscle flap model." | 3.69 | Effector mechanism of adenosine in acute ischemic preconditioning of skeletal muscle against infarction. ( Forrest, CR; He, W; Neligan, P; Pang, CY; Xu, H; Zhong, A, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pang, CY | 1 |
| Neligan, P | 1 |
| Zhong, A | 1 |
| He, W | 1 |
| Xu, H | 1 |
| Forrest, CR | 1 |
1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Infarct
| Article | Year |
|---|---|
Effector mechanism of adenosine in acute ischemic preconditioning of skeletal muscle against infarction.
Topics: Adenosine; Animals; Decanoic Acids; Glyburide; Hydroxy Acids; Infarction; Ischemia; Ischemic Precond | 1997 |